BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10810210)

  • 21. Community-acquired pneumonia in the elderly.
    Fung HB; Monteagudo-Chu MO
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community-acquired pneumonia: the evolving challenge.
    Finch R
    Clin Microbiol Infect; 2001; 7 Suppl 3():30-8. PubMed ID: 11523560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.
    Mandell LA; Marrie TJ; Grossman RF; Chow AW; Hyland RH; ;
    Can Respir J; 2000; 7(5):371-82. PubMed ID: 11058205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community-acquired pneumonia.
    Bartlett JG
    Int J Clin Pract Suppl; 2000 Dec; (115):18-22. PubMed ID: 11219294
    [No Abstract]   [Full Text] [Related]  

  • 25. Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients.
    Martinez FJ
    Clin Infect Dis; 2004 May; 38 Suppl 4():S328-40. PubMed ID: 15127366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nursing home-acquired pneumonia: update on treatment options.
    Mylotte JM
    Drugs Aging; 2006; 23(5):377-90. PubMed ID: 16823991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targets for antibiotic and healthcare resource stewardship in inpatient community-acquired pneumonia: a comparison of management practices with National Guideline Recommendations.
    Jenkins TC; Stella SA; Cervantes L; Knepper BC; Sabel AL; Price CS; Shockley L; Hanley ME; Mehler PS; Burman WJ
    Infection; 2013 Feb; 41(1):135-44. PubMed ID: 23160837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High variability among Emergency Departments in 3rd-generation cephalosporins and fluoroquinolones use for community-acquired pneumonia.
    Batard E; Lecadet N; Goffinet N; Hardouin JB; ; Lepelletier D; Potel G; Montassier E
    Infection; 2015 Dec; 43(6):681-9. PubMed ID: 25998004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Just the berries. Management of community-acquired pneumonia. Evidence-based update.
    Balter M
    Can Fam Physician; 2002 Nov; 48():1773-5. PubMed ID: 12489243
    [No Abstract]   [Full Text] [Related]  

  • 32. Guidelines for severe community-acquired pneumonia in the western world.
    Vegelin AL; Bissumbhar P; Joore JC; Lammers JW; Hoepelman IM
    Neth J Med; 1999 Sep; 55(3):110-7. PubMed ID: 10509069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial treatment of lower respiratory tract infections in the hospital setting.
    Grossman RF; Rotschafer JC; Tan JS
    Am J Med; 2005 Jul; 118 Suppl 7A():29S-38S. PubMed ID: 15993675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-acquired pneumonia: a practical approach to management for the hospitalist.
    Sharpe BA; Flanders SA
    J Hosp Med; 2006 May; 1(3):177-90. PubMed ID: 17219492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones.
    Grossman RF; Hsueh PR; Gillespie SH; Blasi F
    Int J Infect Dis; 2014 Jan; 18():14-21. PubMed ID: 24211230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical pathogens and challenges in community-acquired pneumonia.
    Thibodeau KP; Viera AJ
    Am Fam Physician; 2004 Apr; 69(7):1699-706. PubMed ID: 15086042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolones in community-acquired pneumonia: guide to selection and appropriate use.
    Frei CR; Labreche MJ; Attridge RT
    Drugs; 2011 Apr; 71(6):757-70. PubMed ID: 21504252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
    Roger PM; Risso K; Hyvernat H; Landraud L; Vassallo M; Dellamonica J; de Salvador F; Cua E; Bernardin G
    Med Mal Infect; 2010 Jun; 40(6):347-51. PubMed ID: 20172672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower respiratory tract infections and community acquired pneumonia in adults.
    Stocks N; Turnidge J; Crockett A
    Aust Fam Physician; 2004 May; 33(5):297-301. PubMed ID: 15227857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of treatment guidelines for community-acquired pneumonia.
    Niederman MS
    Am J Med; 2004 Aug; 117 Suppl 3A():51S-57S. PubMed ID: 15360097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.